Chemical stability and human plasma pharmacokinetics of reduced folates

Cancer Investigation

Volumn 16, Issue 7, 1998, Pages 447-455

  Odin, Elisabeth ^a   Carlsson, Göran ^a   Frösing, Roland ^a   Gustavsson, Bengt ^a   Spears, C Paul ^b   Larsson, Per Anders ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLIC ACID DERIVATIVE; FOLINIC ACID; METHYLENETETRAHYDROFOLIC ACID; TETRAHYDROFOLIC ACID;

ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CANCER COMBINATION CHEMOTHERAPY; COLORECTAL CANCER; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031668102     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909809011698     Document Type: Article

References (25)

1. Advanced Colorectal Cancer Meta-analysis project: Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 10:896-903, 1992.
2. Arbuck SG: Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancer. Cancer 63: 1036-1044, 1989.
3. Moertel CG: Chemotherapy for colorectal cancer. N Engl J Med 330:1136-1142, 1994.
4. Danenberg P: Thymidylate synthase - a target enzyme in cancer chemotherapy. Biochem Biophys Acta 473:73-92, 1977.
5. Stover P, Schirch V: The metabolic role of leucovorin. Trends Biochem Sci 18:102-106, 1993.
6. Spears CP, Gustavsson BG, Berne M, et al: Mechanisms of innate resistance to thymidylate synthase inhibition after 5-fluorouracil. Cancer Res 48:5894-5900, 1988.
7. Spears C, Carlsson G, Muggia F, et al: Aspects of one-carbon folate cycling related to fluoropyrimidine and antifolate therapy. In: Chemotherapy: Concepts, Mechanisms, and New Targets for Chemotherapy, edited by FM Muggia. Boston, MA, Kluwer Academic Publishers, 1995, pp. 115-134.
8. Mader R, Steger G, Rizovski B, et al: Stereospecific pharmacokinetics of rac-5-methyltetrahydrofolic acid in patients with advanced colorectal cancer. Br J Pharmacol 40:209-215, 1995.
9. Caldwell W, Lyon J, Dunlap R: An inexpensive apparatus facilitating the storage of oxygen sensitive compounds. Prep Biochem 3:323-326, 1973.
10. O'Broin J, Temprley I, Brown J, et al: Nutritional stability of various naturally occurring monoglutamate derivates of folic acid. Am J Clin Nutr 28:438-444, 1975.
11. Scrimgeour K: Methods for reduction, stabilisation and analyses of folates. Methods Enzymol 66:517-523, 1980.
12. Larsson P-A, Carlsson G, Gustavsson B, et al: Effects of 5,10-methylenetetahydrofolate on rat colon tumour growth and biomodulation of 5-fluorouracil. Reg Cancer Treat 8:101-108, 1995.
13. Rebello T: Trace enrichment of biological folates on solid-phase adsorbtion cartridges and analysis by high-pressure liquid chromatography. Anal Biochem 166:55-64, 1987.
14. Lockshin A, Danenberg PV: Biochemical factors affecting the tightness of 5-fluorodeoxyuridylate binding to human thymidylate synthase. Biochem Pharmacol 30:247-257, 1981.
15. Spears CP, Hayes AA, Shahinian AH, et al: Deoxyuridylate effects on thymidylate synthase-5-fluorodeoxyuridylate-folate ternary complex formation. Biochem Pharmacol 38:2985-2993, 1989.
16. Payet B, Fabre G, Tubiana N, et al: Plasma kinetic study of folinic acid and 5-methyltetrahydrofolate in healthy volunteers and cancer patients by high-performance liquid chromatography. Cancer Chemother Pharmacol 19:319-325, 1987.
17. Smith J, Morris A, Duafala M, et al: Stability of floxuridine and leucovorin calcium admixtures for intraperitoneal administration. Am J Hosp Pharm 46:985-989, 1989.
18. Hawkes J, Villota R: Folates in foods: Reactivity, stability during processing, and nutritional implications. Food Sci. Nutr 28:439-538, 1989.
19. Frei B, England L, Ames B: Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 86:6377-6381, 1989.
20. Schmitz JC, Bunni MA, Priest DG. Dissociation of methylenetetrahydrofolate to tetrahydrofolate and formaldehyde: effect of antioxidants. In Proc 85th Annual Meeting American Association for Cancer Research, San Francisco, CA, April 10-13, 35: March, 1994.
21. Osborn MJ, Talbert PT, Huennekens FM: The structure of "active formaldehyde" (N5,N10-methylene tetrahydrofolic acid). J Am Chem Soc 82:4921-4927, 1960.
22. Schalhorn A, Kühl M: Clinical pharmacokinetics of fluorouracil and folinic acid. Semin Oncol 19:82-92, 1992.
23. McGuire B, Si L, Leese P, et al: Pharmacokinetics of leucovorin calcium after intravenous, intramuscular and oral administration. Clin Pharmacol 7:52-58, 1988.
24. Rustum Y, Trave F, Zakrewski S, et al: Biochemical and pharmacologic basis for potentiation of 5-fluorouracil action by leucovorin. NCI Monogr 165-170, 1987.
25. Shane B: Folylpolyglutamate synthesis and role in the regulation of one-carbon metabolism. Vitam Horm 45:263-335, 1989.